Sunshine Biopharma, Inc

Ownership Transactions Reported by 9 Insiders

Symbol
SBFM, SBFMW on Nasdaq
Industry
Pharmaceutical Preparations
Location
333 Las Olas Way, Cu4 Suite 433, Fort Lauderdale, Florida

Insiders trading volume in the past year

Sunshine Biopharma, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Malek Chamoun 10%+ Owner $2.82M Oct 20, 2022
Rabi Kiderchah Director $248K Oct 31, 2021
James Daniel Kish Director $221K Oct 31, 2021
Camille Sebaaly CFO/Secretary $133K Nov 30, 2022
Steve N. Slilaty Chief Executive Officer, Director, 10%+ Owner $13K +$12K +1200% Mar 4, 2024
Andrew I. Telsey Director $2.29K Oct 31, 2021
Andrew Keller Director Feb 10, 2022
David Natan Director Feb 10, 2022
Marc Beaudoin Chief Operating Officer Jan 26, 2024

Recent Insider Transactions by Companies or Individuals for Sunshine Biopharma, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.